Ivan Bergstein
Overview
Ivan Bergstein received an average of $4M in total compensation, including $500K in salary, at Stemline Therapeutics from 2011 to 2019.
2019Stemline TherapeuticsPresident and Chief Executive Officer
2018Stemline TherapeuticsPresident and Chief Executive Officer
2017Stemline TherapeuticsPresident and Chief Executive Officer
2016Stemline TherapeuticsPresident and Chief Executive Officer
2015Stemline TherapeuticsPresident and Chief Executive Officer
2014Stemline TherapeuticsPresident and Chief Executive Officer
2013Stemline TherapeuticsPresident and Chief Executive Officer
2012Stemline TherapeuticsPresident and Chief Executive Officer
2011Stemline TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 29, 2020, April 30, 2019, April 30, 2018, May 1, 2017, April 8, 2016, April 30, 2015, and April 30, 2014.
Related executives
We found six more executives who work or worked at Stemline Therapeutics.
Kenneth Hoberman
Stemline Therapeutics
Chief Operating Officer
Robert Francomano
Stemline Therapeutics
Chief Commercial Officer
David Gionco
Stemline Therapeutics
Chief Accounting Officer
Eric Rowinsky
Stemline Therapeutics
Chief Medical Officer
Stephen Hall
Stemline Therapeutics
Chief Accounting Officer
John Cavan
Stemline Therapeutics